PL1694646T3 - Sposób syntezy chlorowodorku pioglitazonu - Google Patents

Sposób syntezy chlorowodorku pioglitazonu

Info

Publication number
PL1694646T3
PL1694646T3 PL04806275T PL04806275T PL1694646T3 PL 1694646 T3 PL1694646 T3 PL 1694646T3 PL 04806275 T PL04806275 T PL 04806275T PL 04806275 T PL04806275 T PL 04806275T PL 1694646 T3 PL1694646 T3 PL 1694646T3
Authority
PL
Poland
Prior art keywords
hydrogen chloride
formula
pyridinyl
ethoxy
ethyl
Prior art date
Application number
PL04806275T
Other languages
English (en)
Inventor
János Fischer
Tamás Fodor
Sándor Lévai
Endréné Petényi
Éva Perényi
Original Assignee
Richter Gedeon Vegyeszeti Gyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar Rt filed Critical Richter Gedeon Vegyeszeti Gyar Rt
Publication of PL1694646T3 publication Critical patent/PL1694646T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL04806275T 2003-12-19 2004-12-16 Sposób syntezy chlorowodorku pioglitazonu PL1694646T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0304096A HUP0304096A2 (hu) 2003-12-19 2003-12-19 Eljárás pioglitazon hidrogénklorid előállítására és intermedierjei
EP04806275A EP1694646B1 (en) 2003-12-19 2004-12-16 Process for the synthesis of pioglitazone hydrogen chloride
PCT/HU2004/000118 WO2005058827A1 (en) 2003-12-19 2004-12-16 Process for the synthesis of pioglitazone hydrogen chloride

Publications (1)

Publication Number Publication Date
PL1694646T3 true PL1694646T3 (pl) 2007-09-28

Family

ID=89981865

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04806275T PL1694646T3 (pl) 2003-12-19 2004-12-16 Sposób syntezy chlorowodorku pioglitazonu

Country Status (7)

Country Link
EP (1) EP1694646B1 (pl)
AT (1) ATE360613T1 (pl)
DE (1) DE602004006163T2 (pl)
ES (1) ES2286712T3 (pl)
HU (1) HUP0304096A2 (pl)
PL (1) PL1694646T3 (pl)
WO (1) WO2005058827A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
WO2012153312A1 (en) 2011-05-11 2012-11-15 Ranbaxy Laboratories Limited Process for the purification of pioglitazone
WO2014152843A1 (en) 2013-03-14 2014-09-25 Deuterx, Llc Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
EP3094328B1 (en) 2014-01-15 2020-08-19 Poxel SA Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
ES2926580T3 (es) 2016-12-23 2022-10-27 Minoryx Therapeutics S L Proceso para preparar 5-[[4-[2-[5-(1-hidroxietil)-2-piridinil]etoxi]fenil]metil]-2,4-tiazolidindiona y sales de la misma
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone
WO2025019361A1 (en) 2023-07-14 2025-01-23 Modulation Therapeutics, Inc. Scd1 inhibitors for treating hematolymphoid neoplasms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US5952509A (en) * 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds

Also Published As

Publication number Publication date
DE602004006163D1 (de) 2007-06-06
EP1694646A1 (en) 2006-08-30
EP1694646B1 (en) 2007-04-25
ATE360613T1 (de) 2007-05-15
ES2286712T3 (es) 2007-12-01
DE602004006163T2 (de) 2008-01-03
HU0304096D0 (en) 2004-03-29
HUP0304096A2 (hu) 2005-08-29
WO2005058827A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
RU2202543C2 (ru) Производные 2-(иминометил)аминофенила, способы их получения, соединения, фармацевтическая композиция
US7662971B2 (en) Inhibitors of fatty acid amide hydrolase
CA2636826C (en) Thiazoles as 11 beta-hsd1 inhibitors
KR100645671B1 (ko) 디펩티딜 펩티다제 iv 억제제로서의 n-치환된 피롤리딘유도체
CA2193171A1 (en) Thiazolidinedione derivatives, method for preparing the derivatives and pharmaceutical compositions containing same
US8338599B2 (en) Compounds having a potentiating effect on the activity of ethionamide and uses thereof
JP2005527625A5 (pl)
RU2000101328A (ru) Новые 2-(иминометил)аминофенильные производные, способ их получения, их применение в качестве лекарственных средств и содержащие их фармацевтические композиции
HUT65766A (en) Process for preparing 5-heteroyl-indole derivatives and pharmaceutical compositions containing them
CA2553705A1 (en) 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
PE20080843A1 (es) Inhibidores de renina y metodo para su utilizacion
PL1694646T3 (pl) Sposób syntezy chlorowodorku pioglitazonu
NZ515163A (en) Thiazolidinedione derivative and its use as antidiabetic
JP2009149616A (ja) 置換チアゾリジンジオンの製造方法
MXPA04012630A (es) Proceso para preparar derivados de acido 5-(1,3-oxazol-2-il)benzoico.
TW487707B (en) Improved process for the production of thiazolidinediones and new thiazolidinediones
KR960022515A (ko) 치환된 4-페닐티아졸 유도체, 그 제조방법 및 그를 함유하는 약학적 조성물
Hinklin et al. Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator
AU2008257693B2 (en) Piperidine-amide derivatives
Ünlüsoy et al. Synthesis and antimicrobial activity of some new 3-substituted benzyl-5-(4-chloro-2-piperidin-1yl-thiazole-5-yl-methylene)-thiazolidine-2, 4-dione derivatives
ATE414080T1 (de) Synthese von antidiabetischen rosiglitazonderivaten
CN100381438C (zh) 新的吡咯烷和噻唑烷化合物、它们的制备方法和包含它们的药物组合物
JP2006515888A (ja) アシルアミノチアゾール誘導体、その製造法およびベータ−アミロイドペプチド生成阻害剤としての用途
EA200802245A1 (ru) Способ получения 5-{2-[4-(1,2-бензизотиазол-3-ил)-1-пиперазинил]этил}-6-хлор-1,3-дигидро-2h-индол-2-она (ципразидона)
EP2226321A3 (en) Process for producing thiazolidinediones and intermediates thereof